Everence Capital Management’s CONMED CNMD Stock Holding History

Everence Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,120	Closed	-$224K	–	860
2024 Q3	$224K	Sell	3,120 -800	-20%	-$56.4K	0.01%	688
2024 Q2	$266	Hold	3,920	–	–	0.02%	576
2024 Q1	$314	Hold	3,920	–	–	0.02%	544
2023 Q4	$429K	Hold	3,920	–	–	0.03%	445
2023 Q3	$395	Hold	3,920	–	–	0.03%	458
2023 Q2	$475K	Hold	3,920	–	–	0.04%	359
2023 Q1	$407	Hold	3,920	–	–	0.03%	424
2022 Q4	$347	Hold	3,920	–	–	0.03%	488
2022 Q3	$314K	Hold	3,920	–	–	0.03%	499
2022 Q2	$375K	Hold	3,920	–	–	0.03%	446
2022 Q1	$582K	Hold	3,920	–	–	0.04%	335
2021 Q4	$556K	Hold	3,920	–	–	0.04%	375
2021 Q3	$513K	Buy	3,920 +890	+29%	+$116K	0.04%	390
2021 Q2	$416K	Hold	3,030	–	–	0.03%	448
2021 Q1	$396K	Buy	+3,030	New	+$365K	0.04%	447

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Everence Capital Management's CNMD Position: Q4 2024 in Review

Everence Capital Management sold out of CONMED (CNMD) in Q4 2024, closing a stake of 3,120 shares — an estimated $224K sold.

Everence Capital Management first reported a position in CNMD in Q1 2021 and held it in 15 quarters. The position peaked at $582K in Q1 2022. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

Everence Capital Management reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
Everence Capital Management sold 3,120 CONMED shares in Q4 2024, an estimated $224K.
Everence Capital Management first reported a position in CONMED in Q1 2021 and held it in 15 quarters.
Everence Capital Management's CONMED position peaked at $582K in Q1 2022.
280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.